Window of Opportunity Trial, PARP Inhibitor Rucaparib Affect on PD-L1 Expression in Triple Negative Breast Tumors
Clinical trial NCT03911453 · COMPLETED
Trial details
- NCT number
- NCT03911453
- Sponsor
- University of Arizona
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-19
- Primary completion
- 2021-07-16
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.